logo
Share SHARE
FONT-SIZE Plus   Neg

Active Biotech, Ipsen Present OS Data From Tasquinimod Phase II Study In CRPC

Active Biotech (ATVBF.PK) and Ipsen presented overall survival, or OS, data from the tasquinimod Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer, or CRPC.

The intention-to-treat analysis showed median overall survival times of 33.4 vs. 30.4 months in favor of tasquinimod, longer than previously reported in this metastatic prostate cancer population. A stronger trend for survival benefit is observed in patients with bone metastases. This phase II clinical trial was designed to test the safety and efficacy of tasquinimod.

Noteworthy, 41 patients crossed-over from placebo to tasquinimod. Besides, there were imbalances in baseline prognostic factor in favor of the placebo arm. These were addressed with a multivariate analysis of known CRPC prognostic factors. It showed a statistically significant OS advantage for tasquinimod treated patients with a hazard ratio of 0.64, a decrease of around 40% in the instantaneous risk of event (death), accompanied by improvement in progression-free survival.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After a long gap of fifty years, the first direct commercial flight from U.S. will land in Cuba on Wednesday. JetBlue Flight 387 will be creating a new history by reconnecting direct travel link between the two countries. U.S. Transportation Secretary Anthony Foxx and JetBlue Chief Robin Hayes are there among the first set of travelers to Cuba. Google reportedly plans to expand a car-pooling program to commuters in San Francisco, edging closer to a potential clash with ride-hailing service Uber Technologies Inc. Google, a unit of Alphabet Inc., commenced a pilot car-pooling program around its California headquarters in May this year. Tim Hortons, the Canadian fast-food restaurant chain known for its coffee and doughnuts, has announced plans to launch in Great Britain as part of its efforts to expand internationally. Restaurant Brands International Inc., the parent company of Tim Hortons, said Tuesday that it has established a master franchise joint venture with an investor in Great Britain.
comments powered by Disqus
Follow RTT